<!DOCTYPE html>
<html lang="en-US">
<head>
    <meta charset="utf-8">
    <title>Olivier M. F. Martin</title>
    <script src="document.min.js" userjs="user.js" icon="icon.ico" id="DOC" onerror="var l=document.createElement('link'),s=document.createElement('script');l.rel='stylesheet';l.href='http://netdna.bootstrapcdn.com/bootstrap/3.0.3/css/bootstrap.min.css';l.id='bootstrap.css';l.auto='1';document.head.insertBefore(l,document.getElementById('DOC'));s.src='http://aplib.github.io/document.min.js';document.head.appendChild(s);"></script>
</head>
<body>

<!--fixed-top-bar

-->

<!--header-panel
# Olivier M. F. Martin - Curriculum Vitae
#### [Doctor of Pharmacy, Pharm.D.](https://en.wikipedia.org/wiki/Doctor_of_Pharmacy#France) and [Bioinformatics and Systems Biology Student](http://gss.uva.nl/future-msc-students/life-and-earth-sciences/content33/systems-biology.html)

[Download PDF Version](cv/curriculum_vitae_olivier_martin.pdf)

**Email**: olivmrtn (at) gmail (dot) com

**Github**: [github.com/olivmrtn](http://github.com/olivmrtn/)

**Linkedin**: [linkedin.com/in/olivmrtn](http://www.linkedin.com/in/olivmrtn)
-->

<!--content-panel

---

## Experience

#### Internship
- August 2016 - January 2017 | 5 months
- [Netherlands Cancer Institute](http://www.nki.nl/) - Amsterdam, the Netherlands
- [Computational Cancer Biology](http://ccb.nki.nl/)
- Project: Prediction of irinotecan toxicity using germline next-generation sequencing data
- Whole genome association analysis and machine learning
- Supervised by [Daniel Vis](https://www.linkedin.com/in/danielvis)

#### Internship
- September 2014 - March 2015 | 6 months
- [Hospices Civils de Lyon](http://www.chu-lyon.fr/web/) - Lyon, France
- [Pierre Garraud Geriatric Hospitals, Pharmacy (UMR CNRS 5558)](http://www.chu-lyon.fr/web/Service_Pharmacie%20_2544_2820.html)
- Project: Statistical methods in medical research.
  - Development of [zebu](https://cran.r-project.org/web/packages/zebu/), an R package for local association measures
  - Risk factor analysis of metformin intoxication using R
  - Wrote R code for analysis of pharmacokinetic simulations
- Supervised by [Michel Ducher](https://www.ncbi.nlm.nih.gov/pubmed?term=Michel%20Ducher%5BAuthor%20-%20Full%5D)

#### Internship
- September 2013 - July 2014 | 9 months
- [Institute of Biology and Chemistry of Proteins](http://www.ibcp.fr/?lang=en) - Lyon, France
- [Bioinformatics: Structures and Interactions (UMR CNRS 5086)](http://www.ibcp.fr/mmsb/-Bioinformatique-structures-et-?lang=en)
- Project: Implication of termini in protein-protein interactions
  - Analysis of biological databases (PDB, IntAct) using Python and R
- Supervised by [Juliette Martin](http://perso.ibcp.fr/juliette.martin/)

#### Internship
- June 2011 - July 2011 | 2 months
- [University Health Network](http://www.uhn.ca/) - Toronto, Canada
- [Kotra Research Group](http://kotralab.uhnresearch.ca/)
- Project: Synthesis of Falcipain inhibitors (potential antimalarial drugs)
- Supervised by [Sai Kumar Chaka](http://www.linkedin.com/in/sai-kumar-chakka-178aa215)

#### Student Tutor
- October 2011 - May 2013 | 4 semesters
- [University of Auvergne](http://www.u-clermont1.fr/) - Clermont-Ferrand, France
- [Association du Tutorat de la PACES Clermontoise](http://www.atpclermont.fr/)
- Chemistry and pharmacology tutoring for first-year medical and pharmacy students.

---

## Education

#### [University of Amsterdam](http://www.uva.nl/en/home) and [Vrije Universiteit](http://www.vu.nl/en/index.aspx) - Amsterdam, The Netherlands
- 2015-2017: [M.Sc. Bioinformatics and Systems Biology](http://gss.uva.nl/future-msc-students/life-and-earth-sciences/content33/systems-biology.html)

#### [Claude Bernard University](http://www.univ-lyon1.fr/english-version/home-759942.kjsp?RH=WWW-FR) - Lyon, France
- 2013-2015: [5th and 6th year of Pharmacy, Research Specialisation](http://ispb.univ-lyon1.fr/)
- 2013-2014: [Master 2nd year: Structural and Functional Biochemistry](http://spiralconnect.univ-lyon1.fr/webapp/website/website.html?id=2218791&read=true)

#### [University of Auvergne](http://www.u-clermont1.fr/) - Clermont-Ferrand, France
- 2012-2013: [Master 1st year: Pharmaceutical Sciences](http://pharmacie.u-clermont1.fr/)
- 2009-2013: [1st to 4th year of Pharmacy](http://pharmacie.u-clermont1.fr/)

---

## Programming

- **Main Languages**: R, Python, Shell script, Latex/Markdown, Git
- **Secondary languages**: Mathematica, HTML/CSS/Javascript, SQL

---

## Software

[zebu: Local association measures. R package.](http://github.com/olivmrtn/zebu) [CRAN.](https://cran.r-project.org/web/packages/zebu/) See [vignette](https://cran.r-project.org/web/packages/zebu/vignettes/zebu.html).

---

## Publications

[Martin OMF, Etheve L, Launay G, Martin J. Implication of Terminal Residues at Protein-Protein and Protein-DNA Interfaces. PLoS One. 2016 Sep 9;11(9).](http://www.ncbi.nlm.nih.gov/pubmed/27611671)

[Cazaubon Y, Bourguignon L, Goutelle S, Martin O, Maire P, Ducher M. Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance? Pseudomonas aeruginosa bloodstream infection in elderly patients as a simulation case study. Fundam Clin Pharmacol. 2015 Dec;29(6):615-24.](http://www.ncbi.nlm.nih.gov/pubmed/26406268)

---

## Thesis and Reports

[M.Sc. Literrature Review. Comparison of frequentist and Bayesian methods for inference of gene-regulatory networks. 2016 Jul.](./doc/msc_lit_review_thesis.pdf)

[Pharm.D. Thesis (French). Développement d'un logiciel implémentant une méthode d'analyse de données pour les sciences de la vie. 2015 Jun.](./doc/pharmd_thesis.pdf)

[Internship Report (French). Interactions protéine-protéine. Implication des résidus terminaux. 2014 Jun.](./doc/master2_report.pdf)

[Internship Report. Synthesis of falcipain inhibitors. 2012 Jul.](./doc/master1_report.pdf)

---

## Languages

- **French** and **Portuguese**: Maternal Languages
- **English**: Fluent; TOEFL iBT: 110 / 120
- **Dutch** and **Spanish**: Intermediate Level
- **German** and **Esperanto**: Elementary Level

---

## Annex - Structure of Pharmacy Studies in France

Pharmacy studies in France are structured in three distinct parts:

1. Validation of the first year of Pharmacy is conditioned by a competitive ranking examination. Only a certain number of students defined by the *numerus clausus* are admitted to the second year. In my case, I finished 1st out of 244 students.

2. The second, third and fourth year constitute the common core curriculum. During these years, students are encouraged to obtain a Master 1st year degree.

3. After the fourth year, students choose a specialisation (*e.g.* community pharmacy, industrial pharmacy, research). Pharmacy studies take 6 years (short cycle) or 9 years (long cycle) depending on the specialisation chosen by the student. The research specialisation is a short cycle and corresponds to the fifth and sixth year of Pharmacy studies. It is not available at University of Auvergne which explains my transfer to Claude Bernard University. The fifth year is obtained by equivalence with a Master 2nd year degree. The sixth year is obtained by an internship in a hospital pharmacy and by defending a doctor’s degree in Pharmacy (Pharm.D.).

---
-->


<!--footer-panel
-->

<noscript><div class="alert alert-warning">This Website requires your browser to be JavaScript enabled.</div></noscript>
</body>
</html>
